Sino Biopharmaceutical | 1177 - Current Assets


Sino Biopharmaceutical reported CNY33.82B in Current Assets for its fiscal semester ending in June of 2025.





Current Assets Change Date
Akebia Therapeutics USD 243.48M 9.47M Mar/2026
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Avita Medical AUD 35.49M 760K Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Jiangsu Hengrui CNY 52.04B 553.82M Mar/2026
Moderna USD 5.82B 45M Jun/2026
Organon & Co USD 4.93B 580M Mar/2026
Revvity USD 2.3B 169.4M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026